Nervonik is a Biotech company based in California. It has raised $17M in total funding. Latest round: Series A.
Nervonik funding overview
Nervonik is a Biotech company based in California. Nervonik has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Nervonik runs through 2025; nothing later has been disclosed. Investors on record include U.S. Venture Partners, Foothill Ventures, Correlation Ventures, Shangbay Capital, Camford Capital, Joyance Partners and 2 others. 8 distinct backers are named across the disclosed rounds.
Nervonik at a glance
Total raised
$17M
Latest round
Series A
Latest round date
March 2025
Industry
Biotech
Headquarters
California
Notable investors
U.S. Venture Partners, Foothill Ventures, Correlation Ventures, Shangbay Capital, Camford Capital, Joyance Partners, Life Science Angels, Seraph Group
Frequently asked about Nervonik funding
How much has Nervonik raised?
Nervonik has raised $17M in total disclosed funding across the rounds on record.
Who has invested in Nervonik?
U.S. Venture Partners, Foothill Ventures, Correlation Ventures, Shangbay Capital, Camford Capital, Joyance Partners are named among the investors backing Nervonik.
What was the latest Nervonik funding round?
The most recent disclosed round is a Series A, announced in March 2025.
Where is Nervonik based?
Nervonik is based in California.
What sector does Nervonik operate in?
Nervonik is tracked under Biotech from California, with $17M in disclosed funding.
When did Nervonik last raise?
The last disclosed Nervonik round closed in March 2025 at Series A.
Round data for Nervonik is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in California and backer lists below.
